United States · Funded startup

Who invested in Joyn Bio

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AgtechBiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$200Mraised across 2 rounds since 2017, from 2 sources

$100MSeries A$100MRound
Latest round
Round, $100MMar 2018
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2018
$100MSeries A$100MRound
First round
Series A, $100M
Sept 2017
Biggest round
$100M
Round · Mar 2018
Between rounds
7 months
from the last two

The rounds

  1. Mar 2018
    Round$100M2 new1 returning

    Reported by Agfundernews

  2. Sept 2017
    Series A$100M1 new

    Source recorded

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Viking GlobalVC firm2rounds
BayerCorporate VC1round
GINGKO VENTURESVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Joyn Bio

Who invested in Joyn Bio?

Joyn Bio's investors include Viking Global, Bayer and GINGKO VENTURES.

How much has Joyn Bio raised?

Joyn Bio has raised $200M across 2 rounds since 2017.

When did Joyn Bio last raise?

Joyn Bio's most recent round was an Undisclosed round of $100M in Mar 2018.

What was Joyn Bio's biggest round?

Its most recent round, $100M in Mar 2018, is also its largest on record.

Who backed Joyn Bio first?

Joyn Bio's first round on record, in Sept 2017, was backed by Viking Global.

What stage is Joyn Bio at?

Joyn Bio's latest named round is an Undisclosed round, in Mar 2018.

Where is Joyn Bio based?

Joyn Bio is based in the United States.

Companies like Joyn Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.